Advancements in gene therapy using the Olympus Provi CM20 Incubation Monitoring System

In this video, Eric Blackwood, the Senior Postdoctoral Fellow at the Translational Cardiovascular Research Center, shares insights into the center's research aimed at discovering novel therapeutics for heart failure. The focus lies on small molecule drug-based and gene therapy approaches, utilizing AAV 9 for their investigations. The researchers employ the Olympus Provi CM20 Incubation Monitoring System for monitoring cell proliferation, virus production, and tracking the differentiation of induced pluripotent stem cells into cardiac myocytes. With constant use and real-time monitoring capabilities, the Olympus System contributes to significant time savings and improved research planning, supporting their mission to develop effective treatments for heart failure.